Effect of homocysteine on polymorphonuclear leukocyte activity and luminol-dependent chemiluminescence

Luminescence

Volumn 15, Issue 4, 2000, Pages 257-260

  Zappacosta, B ^a,b   Mordente, A ^a   Persichilli, S ^a   Giardina, B ^a   De Sole, P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Atherosclerosis; Chemiluminescence; Homocysteine; Luminol; Polymorphonuclear leukocytes

Indexed keywords

DISEASES;

2-GENERATED; ATHEROSCLEROSE; DEEP VEIN THROMBOSIS; HOMOCYSTEINES; LUMINOLS; PLASMAS HOMOCYSTEINE; POLYMORPHONUCLEAR LEUKOCYTES; POSSIBLE MECHANISMS; SULFUR AMINO ACIDS; TISSUE FACTORS;

CHEMILUMINESCENCE;

HOMOCYSTEINE; LUMINOL;

ARTICLE; CHEMOLUMINESCENCE; DRUG EFFECT; HUMAN; IN VITRO STUDY; KINETICS; LEUKOCYTE; PHYSIOLOGY;

CHEMILUMINESCENT MEASUREMENTS; HOMOCYSTEINE; HUMANS; KINETICS; LEUKOCYTES; LUMINOL;

EID: 0034222516     PISSN: 15227235     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-7243(200007/08)15:4<257::aid-bio594>3.0.co;2-7     Document Type: Article

References (22)

1. Mudd SH, Levy LH, Skobvy F. Disorders of transsulfuration. In The Metabolic Basis of Inherited Disease, 6th edn. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw Hill: New York, 1989; 693-734.
2. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy. J Lab Clin Med 1989;81:2004-6.
3. Malinow MR. Homocyst(e)ine and arterial occlusive diseases. J Int Med 1994;236:603-17.
4. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997;90:1-11.
5. De Stefano V, Zappacosta B, Persichilli S, Rossi E, Casorelli I, Paciaroni K, Chiusolo P, Leone AM, Giardina B, Leone G. Prevalence of mild hyperhomocysteinemia and association with thrombofilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease. Br J Haematol 1999;106:564-8.
6. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
7. Wall RT, Harlan JM, Harker LA et al. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980;18:113-21.
8. Harker LA, Ross R, Slichter SJ. Homocysteine induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976;58:731-41.
9. Jones BG, Rose FA, Tudball N. Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 1994;105:165-70.
10. Rees MM, Rodgers GM. Homocysteinaemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993;71:337-59.
11. Starkebaum G, Harlan JM. Endothelial cell injury due copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-6.
12. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-18.
13. Olinescu R, Kummerow FA, Handler B, Fleischer L. The hemolytic activity of homocysteine is increased by the activated polymorphonuclear leukocytes. Biochem Biophys Res Commun 1996;226:912-6.
14. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detector. J Chromtogr 1987;422:43-52.
15. De Sole P, Lippa S, Littarru GP. Whole blood chemiluminescence: a new technical approach to assess oxygen-dependent microbicidal activity of granulocytes. J Lab Automation 1983;3:391-400.
16. Boyum A. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. Scand J Clin Lab Invest 1968; 97(suppl 21):51-76.
17. De Sole P, Zappacosta B, Di Mario G. Lactic dehydrogenase activity and its isozymatic pattern in resting and activated human granulocytes. Clin Chem Enzym Comm 1991;4:109-16.
18. Heinecke JW, Kawamura M, Suzuki L, Chait A. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. J Lipid Res 1993;34:2051-61.
19. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
20. Bellamy MF, McDowell IFW. Putative mechanisms for vascular damage by homocysteine. J. Inher. Metab. Dis. 1997;20:307-15.
21. Hankey G, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;354(9176), 407-16.
22. Ikeda U, Ikeda M, Minota, Shimada K. Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Circulation 1999;99:1230-5.